Who owns the FARADAY PHARMACEUTICALS trademark?

The FARADAY PHARMACEUTICALS trademark is owned by Faraday Pharmaceuticals, Inc..

What class is the FARADAY PHARMACEUTICALS trademark registered in?

The FARADAY PHARMACEUTICALS trademark is registered in Class 042 (Scientific, technology & SaaS services).

What is the serial number for FARADAY PHARMACEUTICALS?

The USPTO serial number for FARADAY PHARMACEUTICALS is 88871131.

What is the registration number for FARADAY PHARMACEUTICALS?

FARADAY PHARMACEUTICALS is registered under USPTO registration number 6259625.

FAR

USPTO Trademark Record

REGISTERED

FARADAY PHARMACEUTICALS

SN 88871131·Reg 6259625·Filed Apr 14, 2020

Owner Faraday Pharmaceuticals, Inc.

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

FARADAY PHARMACEUTICALS (Serial No. 88871131), Registration No. 6259625, is a registered US trademark filed on Apr 14, 2020 by Faraday Pharmaceuticals, Inc.. This trademark covers Class 042 (Scientific, technology & SaaS services).

Renewal window: February 02, 2027112 days remaining

Mark Intelligence

FARADAY PHARMACEUTICALS (Reg. #6259625) is a registered US trademark that has been protecting its owner, Faraday Pharmaceuticals, Inc., since 2020. The mark covers Class 042 (Scientific, technology & SaaS services). Goods and services include Scientific and technological services and research and design relating thereto; industrial analysis, industrial research.... The mark faced 1 opposition proceeding during prosecution.

FILED

Apr 14, 2020

SERIAL

88871131

REG#

6259625

REGISTERED

Feb 02, 2021

Owner

Applicant

Faraday Pharmaceuticals, Inc.

Entity

Corporation

State

Address

1616 Eastlake Avenue E, Suite 560, Seattle, WA, 98102

Attorney

NameJohn Paul Oleksiuk

Law firm

John Paul Oleksiuk COOLEY LLP

Docket

320606-20000

Address

1299 PENNSYLVANIA AVENUE, NW, SUITE 700, WASHINGTON, DC 20004-2400, UNITED STATES

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusREGISTERED

Filing DateApr 14, 2020

Serial Number88871131

Registration No.6259625

Registration DateFeb 02, 2021

Status DateFeb 02, 2021

Published for OppositionNov 17, 2020

Mark TypeStandard characters

Attorney Docket320606-20000

Status DescriptionLive and registered

Filing Signals

FILED

2020

YEARS AGO

CLASSES

MADRID FILINGS

Opposed 1× during prosecution

Search 14M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 042Scientific, technology & SaaS services

US codes: 100, 101

First use anywhere: Aug 31, 2015

First use in commerce: Aug 31, 2015

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

15 events

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Feb 02, 2026

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

REGISTERED-PRINCIPAL REGISTER

Feb 02, 2021

REGISTERED-PRINCIPAL REGISTER

PUBLISHED FOR OPPOSITION

Nov 17, 2020

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Nov 17, 2020

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Oct 28, 2020

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

TEAS/EMAIL CORRESPONDENCE ENTERED

Oct 13, 2020

TEAS/EMAIL CORRESPONDENCE ENTERED

APPROVED FOR PUB - PRINCIPAL REGISTER

Oct 13, 2020

APPROVED FOR PUB - PRINCIPAL REGISTER

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Oct 12, 2020

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Oct 12, 2020

CORRESPONDENCE RECEIVED IN LAW OFFICE

ASSIGNED TO EXAMINER

Jul 01, 2020

ASSIGNED TO EXAMINER

NON-FINAL ACTION WRITTEN

Jul 01, 2020

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Jul 01, 2020

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Jul 01, 2020

NOTIFICATION OF NON-FINAL ACTION E-MAILED

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Apr 23, 2020

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Apr 17, 2020

NEW APPLICATION ENTERED

FARADAY PHARMACEUTICALS

Get pre-filing clearance

Search 14M+ trademarks

Run a conflict check

Other Marks by Faraday Pharmaceuticals, Inc.

Other Marks in Class 042 — Scientific, technology & SaaS services

Other Marks by John Paul Oleksiuk

Resources

Company